Novavax (NVAX) Other Gross PP&E Adjustments: 2011-2024
Historic Other Gross PP&E Adjustments for Novavax (NVAX) over the last 6 years, with Dec 2024 value amounting to $25.5 million.
- Novavax's Other Gross PP&E Adjustments fell 86.59% to $25.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $350.6 million, marking a year-over-year increase of 46.58%. This contributed to the annual value of $25.5 million for FY2024, which is 86.59% down from last year.
- As of Q4 2024, Novavax's Other Gross PP&E Adjustments stood at $25.5 million, which was down 86.59% from $189.8 million recorded in Q4 2023.
- In the past 5 years, Novavax's Other Gross PP&E Adjustments registered a high of $244.1 million during Q4 2022, and its lowest value of -$108.7 million during Q3 2022.
- In the last 3 years, Novavax's Other Gross PP&E Adjustments had a median value of -$30.2 million in 2022 and averaged $29.7 million.
- As far as peak fluctuations go, Novavax's Other Gross PP&E Adjustments spiked by 3,760.15% in 2020, and later slumped by 102,477.36% in 2022.
- Quarterly analysis of 5 years shows Novavax's Other Gross PP&E Adjustments stood at $167.4 million in 2020, then increased by 11.56% to $186.7 million in 2021, then soared by 30.72% to $244.1 million in 2022, then declined by 22.25% to $189.8 million in 2023, then tumbled by 86.59% to $25.5 million in 2024.
- Its Other Gross PP&E Adjustments was $25.5 million in Q4 2024, compared to $189.8 million in Q4 2023 and $244.1 million in Q4 2022.